Teza Capital Management’s AbbVie ABBV Stock Holding History

Teza Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$398K	Buy	1,583 +6	+0.4%	+$1.29K	0.77%	55
2026 Q1	$343K	Sell	1,577 -1,141	-42%	-$253K	1.26%	26
2025 Q4	$621K	Buy	2,718 +1,251	+85%	+$285K	2%	10
2025 Q3	$340K	Sell	1,467 -3,062	-68%	-$624K	1.84%	22
2025 Q2	$841K	Buy	4,529 +177	+4%	+$32.9K	0.63%	27
2025 Q1	$912K	Buy	4,352 +2,945	+209%	+$573K	0.42%	67
2024 Q4	$250K	Sell	1,407 -3,629	-72%	-$667K	0.04%	393
2024 Q3	$995K	Buy	5,036 +3,629	+258%	+$677K	0.11%	259
2024 Q2	$241K	Buy	+1,407	New	+$233K	0.03%	499
2024 Q1	–	Sell	-18,884	Closed	-$2.93M	–	548
2023 Q4	$2.93M	Buy	18,884 +14,032	+289%	+$2.05M	0.49%	42
2023 Q3	$723K	Sell	4,852 -48,455	-91%	-$7.11M	0.12%	244
2023 Q2	$7.18M	Buy	+53,307	New	+$7.82M	1.17%	6
2023 Q1	–	Sell	-3,241	Closed	-$524K	–	488
2022 Q4	$524K	Buy	+3,241	New	+$497K	0.1%	314
2022 Q1	–	Sell	-20,012	Closed	-$2.71M	–	398
2021 Q4	$2.71M	Buy	20,012 +16,154	+419%	+$1.91M	0.73%	28
2021 Q3	$416K	Sell	3,858 -53,076	-93%	-$6.06M	0.2%	156
2021 Q2	$6.41M	Buy	+56,934	New	+$6.41M	1.04%	5
2021 Q1	–	Sell	-6,728	Closed	-$721K	–	457
2020 Q4	$721K	Sell	6,728 -19,123	-74%	-$1.84M	0.41%	73
2020 Q3	$2.26M	Buy	+25,851	New	+$2.43M	1.33%	4
2018 Q3	–	Sell	-10,872	Closed	-$1.01M	–	355
2018 Q2	$1.01M	Buy	10,872 +229	+2%	+$22.4K	0.15%	236
2018 Q1	$1.01M	Buy	10,643 +2,479	+30%	+$272K	0.24%	164
2017 Q4	$790K	Buy	+8,164	New	+$769K	0.48%	88
2017 Q2	–	Sell	-14,201	Closed	-$925K	–	2
2017 Q1	$925K	Buy	+14,201	New	+$893K	0.27%	117

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Teza Capital Management's ABBV Position: Q2 2026 in Review

Teza Capital Management increased its AbbVie (ABBV) stake by 0.38% in Q2 2026, buying an estimated $1.29K and bringing the position to 1,583 shares worth $398K. The position accounts for 0.77% of the portfolio, ranked #55.

Teza Capital Management first reported a position in ABBV in Q1 2017 and has held it in 22 quarters since. The position peaked at $7.18M in Q2 2023. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Teza Capital Management held 1,583 shares of AbbVie worth $398K as of Q2 2026.
Teza Capital Management bought 6 AbbVie shares in Q2 2026, an estimated $1.29K.
AbbVie made up 0.77% of Teza Capital Management's portfolio in Q2 2026, its #55 holding.
Teza Capital Management first reported a position in AbbVie in Q1 2017 and has held it in 22 quarters since.
Teza Capital Management's AbbVie position peaked at $7.18M in Q2 2023.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Teza Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.